Shionogi B.V.
5 products tracked · names used in filings: Shionogi B.V.
Upcoming milestones
No upcoming milestones listed.
Recent milestones
Fri 18 Sep 2026🇪🇺 EU approval (EC decision)
Zokovea (ensitrelvir) approved in the EU
Marketing authorisation to Shionogi B.V.; Additional monitoring · source
Tue 23 Jun 2026🇪🇺 CHMP positive opinion
Zokovea (ensitrelvir): CHMP positive opinion
Shionogi B.V.; Additional monitoring · source
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇪🇺 | Zokovea ensitrelvir | Authorised | 2026-09-18 |
| 🇪🇺 | Fetcroja cefiderocol | Authorised | 2020-04-23 |
| 🇪🇺 | Mulpleo (previously Lusutrombopag Shionogi) lusutrombopag | Withdrawn | 2019-02-18 |
| 🇪🇺 | Rizmoic naldemedine | Authorised | 2019-02-18 |
| 🇪🇺 | Senshio ospemifene | Authorised | 2015-01-14 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.